Kingston, Canada

Robert Kisilevsky

USPTO Granted Patents = 13 

Average Co-Inventor Count = 2.5

ph-index = 10

Forward Citations = 258(Granted Patents)


Company Filing History:


Years Active: 1992-2014

Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Kisilevsky

Introduction

Robert Kisilevsky is a prominent inventor based in Kingston, Canada, known for his significant contributions to the field of medical research and treatment. With a total of 13 patents to his name, Kisilevsky has focused on developing innovative solutions for serious health conditions, particularly those related to cardiovascular diseases and amyloidosis.

Latest Patents

Kisilevsky's latest patents include groundbreaking compositions and methods for treating atherosclerosis. One of his notable inventions involves peptides and mimetics of selected domains of mammalian serum amyloid A isoform 2.1 (SAA2.1). These compounds enhance macrophage cholesterol ester hydrolase activity and inhibit acyl CoA:cholesterol acyl transferase activity. Additionally, he has developed methods for using these compositions in the treatment and prevention of atherosclerosis, coronary heart disease, and cardiovascular disease. Another significant patent focuses on sulfonated compounds and compositions for treating amyloidosis. This invention describes therapeutic compounds and methods for inhibiting amyloid deposition in subjects, regardless of the clinical setting. The administration of these therapeutic compounds, which include anionic groups and carrier molecules, effectively inhibits the interaction between amyloidogenic proteins and basement membrane constituents.

Career Highlights

Throughout his career, Robert Kisilevsky has worked with esteemed organizations, including Queen's University at Kingston and The Upjohn Company. His work has significantly advanced the understanding and treatment of complex diseases, showcasing his dedication to medical innovation.

Collaborations

Kisilevsky has collaborated with notable colleagues, including Walter A. Szarek and Donald F. Weaver. These partnerships have contributed to the development of his innovative patents and research.

Conclusion

Robert Kisilevsky's contributions to medical research and innovation have made a lasting impact on the treatment of cardiovascular diseases and amyloidosis. His work exemplifies the importance of scientific advancement in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…